Vital Images to market VoxelView
Vital Images last week said it received 510(k) clearance fromthe Food and Drug Administration for its VoxelView 3-D workstation.VoxelView is based on a Silicon Graphics computer and employs3-D volume rendering and proprietary algorithms to give
Vital Images last week said it received 510(k) clearance fromthe Food and Drug Administration for its VoxelView 3-D workstation.VoxelView is based on a Silicon Graphics computer and employs3-D volume rendering and proprietary algorithms to give radiologistsand surgeons a noninvasive view of internal anatomy.
The Fairfield, IA, company made its first appearance at theRadiological Society of North America meeting last month, providingvisitors with virtual tours of nasal passages, colons and thecircle of Willis. Vital Images plans to market VoxelView on botha direct and indirect basis, according to Andrew Weiss, president.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
